Label-free enrichment of functional cardiomyocytes using microfluidic deterministic lateral flow displacement

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Zhang, Boyang ^a,c   Green, James V ^b   Murthy, Shashi K ^b   Radisic, Milica ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b Northeastern University   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; CELL DENSITY; CELL ISOLATION; CELL POPULATION; CELL SELECTION; CELL SEPARATION; CELL SIZE; CELL SUSPENSION; CELL THERAPY; CELL VIABILITY; CONTROLLED STUDY; DETERMINISTIC LATERAL DISPLACEMENT; ENRICHMENT CULTURE; FLOW RATE; FLUID FLOW; HEART MUSCLE CELL; HYDRODYNAMICS; MICROFLUIDIC ANALYSIS; MICROFLUIDICS; NEWBORN; NONHUMAN; PHYSICAL PERFORMANCE; RAT; SYRINGE; TISSUE ENGINEERING; ANIMAL; CYTOLOGY; INSTRUMENTATION; METABOLISM;

RATTUS;

ANIMALS; ANIMALS, NEWBORN; CELL SEPARATION; CELL SIZE; HYDRODYNAMICS; MICROFLUIDIC ANALYTICAL TECHNIQUES; MYOCYTES, CARDIAC; RATS; TISSUE ENGINEERING;

EID: 84861535388     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037619     Document Type: Article

References (45)

1. Rosamond W, Flegal K, Furie K, Go A, et al. Writing Group Members (2008) Heart Disease and Stroke Statistics-2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117: e25-146.
2. Laflamme MA, Murry CE, (2005) Regenerating the heart. Nat Biotechnol 23: 845-856.
3. Soonpaa MH, Field LJ, (1998) Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circulation Research 83: 15-26.
4. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe-Heider F, et al. (2009) Evidence for cardiomyocyte renewal in humans. Science 324: 98-102.
5. Murry CE, Field LJ, Menasche P, (2005) Cell-based cardiac repair: reflections at the 10-year point. Circulation 112: 3174-3183.
6. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, et al. (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410: 701-705.
7. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, et al. (2004) Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428: 664-668.
8. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, et al. (2004) Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428: 668-673.
9. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD, (2002) Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105: 93-98.
10. Shake JG, Gruber PJ, Baumgartner WA, Senechal G, Meyers J, et al. (2002) Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 73: 1919-1925; discussion 1926.
11. Muller-Ehmsen J, Peterson KL, Kedes L, Whittaker P, Dow JS, et al. (2002) Rebuilding a damaged heart: long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation 105: 1720-1726.
12. Reinecke H, Zhang M, Bartosek T, Murry CE, (1999) Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation 100: 193-202.
13. Huwer H, Winning J, Vollmar B, Welter C, Lohbach C, et al. (2003) Long-term cell survival and hemodynamic improvements after neonatal cardiomyocyte and satellite cell transplantation into healed myocardial cryoinfarcted lesions in rats. Cell Transplant 12: 757-767.
14. Li RK, Jia ZQ, Weisel RD, Mickle DA, Zhang J, et al. (1996) Cardiomyocyte transplantation improves heart function. Ann Thorac Surg 62: 654-660; discussion 660-651.
15. Soonpaa MH, Koh GY, Klug MG, Field LJ, (1994) Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science 264: 98-101.
16. Dengler J, Radisic M, (2007) Tissue engineering approaches for the development of a contractile cardiac patch. Future Cardiol 3: 425-434.
17. Dar A, Shachar M, Leor J, Cohen S, (2002) Cardiac tissue engineering Optimization of cardiac cell seeding and distribution in 3D porous alginate scaffolds. Biotechnology and bioengineering 80: 305-312.
18. Zimmermann WH, Melnychenko I, Wasmeier G, Didie M, Naito H, et al. (2006) Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 12: 452-458.
19. Yang L, Soonpaa MH, Adler ED, Roepke TK, Kattman SJ, et al. (2008) Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 453: 524-528.
20. Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, et al. (2009) Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 104: e30-41.
21. Langer R, (2007) Editorial: tissue engineering: perspectives, challenges, and future directions. Tissue Engineering 13: 1-2.
22. Radisic M, Park H, Martens TP, Salazar-Lazaro JE, Geng W, et al. (2007) Pre-treatment of synthetic elastomeric scaffolds by cardiac fibroblasts improves engineered heart tissue. J Biomed Mater Res A.
23. Naito H, Melnychenko I, Didie M, Schneiderbanger K, Schubert P, et al. (2006) Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation 114: I72-78.
24. Stevens KR, Kreutziger KL, Dupras SK, Korte FS, Regnier M, et al. (2009) Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proc Natl Acad Sci U S A 106: 16568-16573.
25. Dvir T, Kedem A, Ruvinov E, Levy O, Freeman I, et al. (2009) Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc Natl Acad Sci U S A 106: 14990-14995.
26. Brown MA, Iyer RK, Radisic M, (2008) Pulsatile perfusion bioreactor for cardiac tissue engineering. Biotechnol Prog 24: 907-920.
27. Zandstra PW, Bauwens C, Yin T, Liu Q, Schiller H, et al. (2003) Scalable production of embryonic stem cell-derived cardiomyocytes. Tissue Eng 9: 767-778.
28. Hattori F, Chen H, Yamashita H, Tohyama S, Satoh YS, et al. (2010) Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat Methods 7: 61-66.
29. Dubois NC, Craft AM, Sharma P, Elliott DA, Stanley EG, et al. (2011) SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat Biotechnol.
30. Perin EC, Dib N, Silva GV, DeMaria AN, Marroquin OC, et al. (2011) A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells inPatients With Ischemic and Nonischemic Heart Failure. American Heart Association.
31. Iyer RK, Chui J, Radisic M, (2009) Spatiotemporal tracking of cells in tissue-engineered cardiac organoids. Journal of Tissue Engineering and Regenerative Medicine 3: 196-207.
32. AC N, (1980) Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution. Cytobios 20.
33. Murthy SK, Sethu P, Vunjak-Novakovic G, Toner M, Radisic M, (2006) Size-based microfluidic enrichment of neonatal rat cardiac cell populations. Biomed Microdevices 8: 231-237.
34. Huang LR, Cox EC, Austin RH, Sturm JC, (2004) Continuous Particle Separation through Deterministic Lateral Displacement. Science 304: 987-990.
35. Inglis DW, Davis JA, Zieziulewicz TJ, Lawrence DA, Austin RH, et al. (2008) Determining blood cell size using microfluidic hydrodynamics. J Immunol Methods 329: 151-156.
36. Green JV, Radisic M, Murthy SK, (2009) Deterministic lateral displacement as a means to enrich large cells for tissue engineering. Anal Chem 81: 9178-9182.
37. Inglis DW, Davis JA, Austin RH, Sturm JC, (2006) Critical particle size for fractionation by deterministic lateral displacement. Lab Chip 6: 655-658.
38. Cooper R, Lee L, (2007) Chips & Tips: Preventing suspension settling during injection. Lab on a Chip.
39. Naito H, Melnychenko I, Didié M, Schneiderbanger K, Schubert P, et al. (2006) Optimizing Engineered Heart Tissue for Therapeutic Applications as Surrogate Heart Muscle. Circulation 114: I-72-I-78.
40. Heidi Au HT, Cui B, Chu ZE, Veres T, Radisic M, (2009) Cell culture chips for simultaneous application of topographical and electrical cues enhance phenotype of cardiomyocytes. Lab Chip 9: 564-575.
41. Dengler J, Song H, Thavandiran N, Masse S, Wood GA, et al. (2010) Engineered heart tissue enables study of residual undifferentiated embryonic stem cell activity in a cardiac environment. Biotechnol Bioeng.
42. McDonald JC, Duffy DC, Anderson JR, Chiu DT, Wu H, et al. (2000) Fabrication of microfluidic systems in poly(dimethylsiloxane). Electrophoresis 21: 27-40.
43. Radisic M, Park H, Shing H, Consi T, Schoen FJ, et al. (2004) Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proceedings of the National Academy of Sciences of the United States of America 101: 18129-18134.
44. Au HT, Cheng I, Chowdhury MF, Radisic M, (2007) Interactive effects of surface topography and pulsatile electrical field stimulation on orientation and elongation of fibroblasts and cardiomyocytes. Biomaterials 28: 4277-4293.
45. Tandon N, Cannizzaro C, Chao PH, Maidhof R, Marsano A, et al. (2009) Electrical stimulation systems for cardiac tissue engineering. Nat Protoc 4: 155-173.